StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
20
This year
1
Publishing Date
2024 - 01 - 15
1
2023 - 10 - 05
1
2023 - 09 - 26
1
2023 - 07 - 21
1
2023 - 03 - 31
1
2023 - 03 - 24
1
2023 - 03 - 20
1
2023 - 02 - 09
1
2022 - 08 - 25
1
2022 - 08 - 17
1
2022 - 08 - 01
1
2022 - 06 - 17
1
2022 - 06 - 14
1
2022 - 04 - 06
1
2022 - 02 - 16
1
2022 - 02 - 15
1
2022 - 01 - 25
1
2022 - 01 - 18
1
2021 - 11 - 18
2
Sector
Commercial services
2
Health services
3
Health technology
20
Manufacturing
9
Tags
Acquisition
4
Agreement
3
Alliances
18
Asco
2
Australia
9
Awards
2
Biocanada
3
Bioforest
2
Cancer
12
Cell
4
Clinical-trials-phase-ii
4
Collaboration
11
Conference
8
Contract
3
Designation
6
Diabetes
7
Disease
4
Drug
20
Drug discovery
6
Earnings
6
Europe
13
Events
5
Evt801
4
Exs-2154
3
Fda
3
Glioblastoma
3
Global
11
Grant
4
Growth
6
Market
18
Meeting
7
Molecular
4
Money
4
N/a
54
News
6
Ongoing
3
Partnership
20
Paxalisib
21
People
7
Pharmaceutical
13
Phase 1
3
Phase 2
3
Pipeline
3
Platform
3
Positive
4
Preclinical
4
Presentation
3
Program
5
Rare
3
Research
11
Results
6
Sciences
3
Services
4
Study
9
Therapeutics
25
Therapy
4
Train
9
Treatment
8
Trial
4
Year
3
Entities
3m company
10
Abbott laboratories
64
Abbvie inc.
75
Agilent technologies, inc.
10
Aldeyra therapeutics, inc.
10
Aligos therapeutics, inc.
17
Alnylam pharmaceuticals, inc.
11
Amgen inc.
54
Arcutis biotherapeutics, inc.
11
Ardelyx, inc.
11
Arrival
11
Astellas pharma inc
26
Astrazeneca plc
69
Bausch health companies inc.
22
Baxter international inc.
15
Becton, dickinson and company
34
Bio-rad laboratories, inc.
12
Biogen inc.
28
Boston scientific corporation
13
Bristol-myers squibb company
63
Calliditas therapeutics ab
10
Catalent, inc.
10
Certara inc
11
Charles river laboratories international, inc.
13
Danaher corporation
14
Eli lilly and company
105
Endo international plc
13
Enveric biosciences inc
12
Evotec se
20
Galapagos nv
12
Gilead sciences, inc.
25
Glaxosmithkline plc
109
Hoth therapeutics, inc.
12
I-mab
11
Incyte corporation
33
Intelligent bio solutions inc
19
Ionis pharmaceuticals, inc.
14
Jaguar health, inc.
33
Johnson & johnson
224
Laboratory corporation of america holdings
14
Lantern pharma inc.
33
Lexaria bioscience corp
11
Mannkind corporation
12
Medtronic plc
24
Nanoviricides, inc.
21
Novartis ag
115
Novo nordisk a/s
18
Orange
27
Perrigo company
13
Pfizer, inc.
54
Sanofi
240
Sorrento therapeutics, inc.
11
Sutro biopharma, inc.
12
Takeda pharmaceutical company limited
29
Teva pharmaceutical industries ltd
44
Thermo fisher scientific inc
48
Tonix pharmaceuticals holding corp.
12
Viatris inc.
15
West pharmaceutical services, inc.
14
Zai lab limited
11
Symbols
CERT
1
CRL
2
EVO
9
EVOTF
20
JNJ
3
KZIA
1
LH
3
LLY
2
TMO
2
Exchanges
Nasdaq
20
Nyse
9
Crawled Date
2024 - 01 - 15
1
2023 - 10 - 05
1
2023 - 09 - 26
1
2023 - 07 - 21
1
2023 - 03 - 31
1
2023 - 03 - 24
1
2023 - 03 - 20
1
2023 - 02 - 09
1
2022 - 08 - 25
1
2022 - 08 - 17
1
2022 - 08 - 01
1
2022 - 06 - 17
1
2022 - 06 - 14
1
2022 - 04 - 06
1
2022 - 02 - 16
1
2022 - 02 - 15
1
2022 - 01 - 25
1
2022 - 01 - 18
1
2021 - 11 - 18
2
Crawled Time
04:00
1
05:00
1
08:00
2
09:00
2
10:00
3
11:00
1
12:20
1
12:30
1
13:00
2
13:20
1
15:00
1
17:00
1
20:00
1
22:00
1
23:00
1
Source
www.biospace.com
13
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Drug
entities :
Evotec se
save search
Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight
Published:
2024-01-15
(Crawled : 22:00)
- prnewswire.com
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
16.78%
|
O:
0.15%
H:
0.59%
C:
-1.45%
drug
treatment
heart
market
65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Singapore
Published:
2023-10-05
(Crawled : 05:00)
- prnewswire.com
EVOTF
|
News
|
$21.68
30.35%
3.2K
|
Health Technology
|
Email alert
Add to watchlist
partnership
drug
company
global
Novo Nordisk and Evotec collaborate to launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases
Published:
2023-09-26
(Crawled : 13:00)
- biospace.com/
EVOTF
|
News
|
$21.68
30.35%
3.2K
|
Health Technology
|
Email alert
Add to watchlist
drug
innovation
Drug Discovery Informatics Market size to Grow by USD 4,953.48 million from 2022 to 2027|Increasing R&D investments by pharmaceutical and biopharmaceutical companies drive the market - Technavio
Published:
2023-07-21
(Crawled : 04:00)
- prnewswire.com
CERT
|
$16.21
-4.37%
-4.69%
490K
|
|
-10.3%
|
O:
1.26%
H:
1.5%
C:
0.57%
TMO
|
News
|
$541.52
-1.05%
-0.1%
1.8M
|
Health Technology
|
-0.98%
|
O:
0.07%
H:
4.84%
C:
4.37%
drug
investments
companies
market
Global Drug Discovery Services Market Report 2023: Increasing Drug R&D Pipeline and Rising Reliance on Outsourcing Fuels Growth
Published:
2023-03-31
(Crawled : 23:00)
- prnewswire.com
EVOTF
|
News
|
$21.68
30.35%
3.2K
|
Health Technology
|
Email alert
Add to watchlist
LH
M
|
$199.45
-0.26%
0.0%
770K
|
Health Services
|
Email alert
Add to watchlist
CRL
|
$227.55
-1.1%
0.0%
710K
|
Commercial Services
|
Email alert
Add to watchlist
drug
services
report
pipeline
global
growth
market
Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis
Published:
2023-03-24
(Crawled : 09:00)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-26.48%
|
O:
-2.01%
H:
0.21%
C:
0.21%
drug
grant
Drug Discovery Services Market worth $41.3 billion | MarketsandMarkets
Published:
2023-03-20
(Crawled : 17:00)
- prnewswire.com
TMO
|
News
|
$541.52
-1.05%
-0.1%
1.8M
|
Health Technology
|
-2.62%
|
O:
-0.11%
H:
1.48%
C:
0.7%
LH
M
|
$199.45
-0.26%
0.0%
770K
|
Health Services
|
-6.26%
|
O:
0.35%
H:
1.63%
C:
1.55%
drug
services
market
Evotec and Related Sciences Expand Integrated Drug Discovery and Development Partnership
Published:
2023-02-09
(Crawled : 10:00)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-29.29%
|
O:
1.19%
H:
0.0%
C:
-2.85%
partnership
sciences
drug
Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany
Published:
2022-08-25
(Crawled : 09:00)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-39.35%
|
O:
0.26%
H:
0.59%
C:
-0.59%
acquisition
drug
glass
commercial
germany
PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials
Published:
2022-08-17
(Crawled : 13:20)
- biospace.com/
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-12.66%
|
O:
0.4%
H:
0.0%
C:
0.0%
trials
drug
collaboration
phase 2
Rubedo Life Sciences Expands Leadership Team with Ali Siam as Chief Business Officer and Ofir Moreno, Ph.D., as SVP of Drug Discovery
Published:
2022-08-01
(Crawled : 13:00)
- biospace.com/
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-16.63%
|
O:
0.22%
H:
0.0%
C:
0.0%
sciences
drug
life
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER
Published:
2022-06-17
(Crawled : 12:20)
- prnewswire.com
KZIA
|
$0.3462
0.58%
2.27%
270K
|
Health Technology
|
-93.54%
|
O:
18.42%
H:
2.42%
C:
-15.4%
fda
rare
designation
awards
drug
cancer
paxalisib
train
Evotec Enters a Drug Discovery Collaboration with Janssen
Published:
2022-06-14
(Crawled : 08:00)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-42.16%
|
O:
-3.33%
H:
0.5%
C:
-1.85%
JNJ
|
News
|
$145.74
0.67%
-0.18%
7M
|
Health Technology
|
-14.89%
|
O:
0.43%
H:
0.0%
C:
0.0%
drug
collaboration
Novel Drug From Neuro-Bio Effective in a Mouse Model of Alzheimer’s Disease
Published:
2022-04-06
(Crawled : 08:00)
- biospace.com/
EVOTF
|
News
|
$21.68
30.35%
3.2K
|
Health Technology
|
Email alert
Add to watchlist
drug
disease
alzheimer’s
alzheimer's
Global Drug Discovery Services Market (2021 to 2026) - Rising Demand for Specialized Testing Services Among End-users Presents Opportunities
Published:
2022-02-16
(Crawled : 20:00)
- prnewswire.com
LH
M
|
$199.45
-0.26%
0.0%
770K
|
Health Services
|
-25.83%
|
O:
-0.27%
H:
0.21%
C:
-2.59%
CRL
|
$227.55
-1.1%
0.0%
710K
|
Commercial Services
|
-23.89%
|
O:
0.24%
H:
0.18%
C:
-4.7%
ema
drug
services
test
drug discovery
IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE
Published:
2022-02-15
(Crawled : 15:00)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-54.09%
|
O:
3.68%
H:
0.68%
C:
0.19%
drug
research
drug discovery
Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology
Published:
2022-01-25
(Crawled : 10:00)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-64.17%
|
O:
-0.96%
H:
0.81%
C:
-1.12%
partnership
drug
drug discovery
Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases
Published:
2022-01-18
(Crawled : 11:00)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-64.84%
|
O:
-3.16%
H:
2.55%
C:
0.82%
LLY
|
$745.95
-0.64%
-0.81%
1.3M
|
Health Technology
|
199.97%
|
O:
-3.01%
H:
2.38%
C:
1.78%
metabolic
drug
disease
collaboration
drug discovery
EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership
Published:
2021-11-18
(Crawled : 12:30)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-68.79%
|
O:
4.43%
H:
2.27%
C:
1.05%
partnership
drug discovery
drug
Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership
Published:
2021-11-18
(Crawled : 10:00)
- biospace.com/
EVO
|
News
|
$7.15
-1.24%
-0.7%
27K
|
Manufacturing
|
-68.79%
|
O:
4.43%
H:
2.27%
C:
1.05%
partnership
drug discovery
drug
Gainers vs Losers
60%
40%
Top 10 Gainers
AGBA
|
News
|
$1.03
157.5%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.52
100.0%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.5
45.65%
470K
|
OST
|
$0.509
23.81%
45.26%
90K
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.15
63.21%
37.74%
16M
|
TIRX
|
$0.8
65.02%
30.74%
58M
|
BNTC
|
News
|
$6.82
42.08%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.